-based Stryker, inaugurated a new research and development facility in India, expanding its innovation capabilities. The 55,600-square-foot lab is equipped with microbiology facilities and teams dedicated to developing pioneering medical technologies.
The facility features plastic 3D printing and metal machining capabilities, highlighting Stryker’s focus on additive manufacturing (AM) as a key growth strategy. Since 2013, the company says it has 3D printed over 2 million “Tritanium” implants.
According to the company website, Tritanium In-Growth Technology is used to build the Tritanium PL Cage, designed for bone in‑growth and biological fixation. You can read more about this technology here.
Ram Rangarajan, vice president of Stryker Global Technology Center, India, emphasized the company’s strategy to invest in Indian innovation, recognizing the country’s potential to contribute significantly to global healthcare solutions.
Beyond innovation, Stryker has demonstrated a strong commitment to sustainability. The company conducted a Life Cycle Assessment to showcase the environmental benefits of AM compared to traditional manufacturing methods.
Rangarajan added, “This lab expansion further strengthens our Stryker Global Technology Center and marks a significant milestone in our commitment toward fostering innovation from India. By leveraging the talent and expertise in the country, Stryker aims to develop medical technologies that benefit patients worldwide.”
Last updated: December 26th, 2025
